Therapeutic Options Used for Myasthenia Gravis

J Gordon Millichap

doi:10.15844/pedneurbriefs-25-2-7

Therapeutic Options Used for Myasthenia Gravis

Pediatric Neurology Briefs

Volume 25 (2011): Issue 2

By: J Gordon Millichap

Open Access

|Feb 2011

Abstract

Clinical and economic outcomes following plasma exchange (PLEX) and intravenous immunoglobulin (IVIG) in 1,606 hospitalized adult patients with myasthenia gravis (MG) were compared in a study at Case Western Reserve University, Cleveland, OH; St Louis University, MO; and University of Alabama, Birmingham, AL.

References

Mandawat A Kaminski HJ Cutter G Katirji B Alshekhlee A Comparative analysis of therapeutic options used for myasthenia gravis Ann Neurol 2010 Dec 68 6 797 805 10.1002/ana.22139 21061395
Open DOI Search in Google Scholar Back to article
Miller RG Barohn RJ Dubinsky R Expanding the evidence base for therapeutics in myasthenia gravis Ann Neurol 2010 Dec 68 6 776 7 10.1002/ana.22256 21194147
Open DOI Search in Google Scholar Back to article
Tracy MM McRae W Millichap JG Graded response to thymectomy in children with myasthenia gravis J Child Neurol 2009 Apr 24 4 454 9 10.1177/0883073808325653 19339286
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-25-2-7 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 14 - 14

Published on: Feb 1, 2011

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Respiratory,

Cardiac,

Renal Failure

© 2011 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 25 (2011): Issue 2